NV-RIMINI-STREET,-INC.
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of business software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today revealed significant findings from its recent survey of Oracle PeopleSoft licensees, which was conducted to better understand licensees’ software product and release roadmap strategies, current challenges and application support and operating plans. The survey highlights that an overwhelming 97% of respondents believe their current PeopleSoft releases meet all or most of their business needs. Further, many licensees are taking steps to maximize the value and extend the lifespan of their robust and mature current releases, including moving their PeopleSoft software to a cloud hosting platform, utilizing Application Management Services and switching their annual support to third-party support providers like Rimini Street.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005176/en/
Oracle licensees who responded to the Rimini Street survey include a mix of CIOs and VPs of IT, IT directors and managers, application managers, application leads and Oracle administrators across a variety of industries including Financial Services, Retail, Manufacturing, Education, Telecommunications, Building and Construction, Government, Transportation and Logistics, Pharmaceutical and Life Sciences, Insurance, and Oil and Gas.
To access a copy of Rimini Street’s report, “Survey Report: Licensees’ Insights into the Future of Their PeopleSoft Roadmaps,” click here .
Licensees Maximizing the Value and Extending the Lifespan of Current Releases
Instead of investing significant time, resources and capital to perform what they view as expensive, low ROI release upgrades or full migrations to Oracle Cloud ERP, many PeopleSoft licensees are taking steps to maximize the value and extend the lifespan of their current, robust and mature releases.
For example, despite PeopleSoft 9.2 being generally available since March 20131 , 64% of respondents are still running at least part of their business on PeopleSoft 9.1 or earlier releases, which are no longer fully supported by Oracle. Currently, less than 50% of respondents have indicated any definitive plans to upgrade their PeopleSoft applications.
Vendor Support is Expensive and Provides Low Value for PeopleSoft 9.1 or Earlier Releases
For PeopleSoft licensees who are continuing to utilize their current PeopleSoft 9.1 or earlier release and have chosen not to upgrade to PeopleSoft 9.2, they are now in Oracle Sustaining Support and no longer get access to new fixes, critical patch updates or tax, legal and regulatory updates. Despite the reduced service breadth, 72% of respondents running PeopleSoft 9.1 or earlier releases are still paying Oracle for expensive and low value Sustaining Support that does not meet their full support needs, resulting in 43% of these same PeopleSoft licensees also paying Oracle additional fees for supplemental critical tax, legal and regulatory updates, and 39% having to allocate their own resources to help fill the service gap by self-supporting their PeopleSoft environments.
PeopleSoft 9.2 Provides Limited Additional Business Value and ROI
Of those licensees who are currently planning to eventually upgrade to PeopleSoft 9.2, nearly 85% indicated they are doing so primarily for support reasons and not to implement or leverage the benefits of any new features or functional enhancements. In fact, according to a poll by the Quest Oracle Community, nearly half of PeopleSoft 9.2 licensees have rolled out zero new features to end users2 .
Of the respondents who are running PeopleSoft 9.2, 53% indicated that they did not leverage strong innovation on a consistent basis from new Oracle PeopleSoft 9.2 updates. However, despite the updates providing a seemingly low ROI and value, 96% indicated it can be very expensive and time-consuming to apply the Oracle PeopleSoft 9.2 updates, taking up to six weeks to test, validate and apply just one update, requiring an average of three-to-five resources during that time to perform the work.
Despite these significant cost and resources needed to complete an Oracle PeopleSoft 9.2 update, the majority of PeopleSoft 9.2 survey respondents appear to stay current with Oracle’s updates primarily to ensure that they retain access to Oracle full support.
PeopleSoft Licensees are Leveraging the Cloud to Extend the Lifespan of Current Releases
The survey also revealed that cloud continues to play an integral role in the future of licensees’ PeopleSoft roadmaps, with 87% of all respondents currently evaluating, actively moving to, or already running some or all their PeopleSoft applications on a cloud platform. Migrating their PeopleSoft system to a cloud environment can eliminate the need for significant capital investments in data center server refreshes, reduce operating costs and provide better user performance. In fact, 29% of respondents indicate that they have already migrated their PeopleSoft system to a cloud hosting provider. Lifting and shifting existing PeopleSoft software to a cloud environment provides the cloud-related benefits noted above, while allowing the respondents to extend the lifespan of their proven, current software releases for many additional years without having to address aging hardware infrastructure challenges.
Challenges with Oracle Support Persist
Finally, the survey underscores that challenges persist with regard to Oracle annual maintenance and support in comparison to the perceived benefit of that support, consistent with findings from a 2019 survey . The number one issue surfaced in the current survey, cited by 56% of all respondents, is the high annual maintenance and support fees charged by Oracle. Additionally, 43% of respondents cited dissatisfaction with the time it takes for Oracle to respond to issues, 43% of respondents noted that they have to escalate priority tickets to get the right expertise, and 16% of respondents were dissatisfied that Oracle annual maintenance and support does not provide support for customizations as a standard feature.
Rimini Street Helps Organizations Take Back Control of PeopleSoft Roadmaps
Rimini Street enables clients to maximize the value and extend the lifespan of current PeopleSoft releases by saving 50% on vendor annual support fees and up to 90% on the total cost of maintenance for PeopleSoft, while supporting their existing PeopleSoft releases for a minimum of an additional 15 years without any forced upgrades or updates. Clients enjoy faster, more comprehensive support including 10-minute response SLAs for critical P1 issues, the industry’s fastest Legislature-to-LiveTM tax, legal and regulatory updates, and support for custom code and integrations, all at no extra cost. With Rimini Street, IT organizations running PeopleSoft are able to leverage immediate budget and time savings to focus on the strategic priorities of their business, without Oracle dictating their roadmap decisions or timing.
“While our PeopleSoft 9.2 software release more than meets our business needs, we were struggling to justify the cost required to support the platform. In comparison to the cost, time and resources required for us to keep up to date on the vendor’s forced updates just to remain in full support, we were not getting sufficient support from the vendor in return,” said Ho Lee, HR and IT Service Team Leader, Kolon Benit. “We moved to Rimini Street Support and now save significantly on our annual maintenance, plus we are guaranteed a minimum of 15 years’ support for our current PeopleSoft software release. This has enabled us to free up significant resource and budget to focus on more strategic initiatives within the business.”
“Our PeopleSoft survey indicates an overall trend that many PeopleSoft licensees are taking steps to maximize the value and extend the useful life of their current PeopleSoft releases, but they need a better support solution that provides more value at a lower cost, and doesn’t require any forced upgrades or updates for years to come,” said Frank Reneke , group vice president and general manager, Oracle Services, Rimini Street. “PeopleSoft licensees who switch to Rimini Street Support can extend the lifespan of their existing release for a minimum of 15 years with no required updates, upgrades or migrations at up to a 90% total maintenance and support cost savings. Tax, legal and regulatory updates and full customization support are included at no additional charge. They can also leverage Rimini Street Application Management Services for PeopleSoft to run their system – creating an efficient, managed ‘turnkey’ solution that integrates operations and support into a single offering, provided by a single, fully-accountable vendor.”
For more information on Rimini Street Support for PeopleSoft click here .
About Rimini Street, Inc.
Rimini Street, Inc. (Nasdaq: RMNI) is a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner. The Company offers premium, ultra-responsive and integrated application management and support services that enable enterprise software licensees to save significant costs, free up resources for innovation and achieve better business outcomes. To date, more than 3,500 Fortune 500, Fortune Global 100, midmarket, public sector and other organizations from a broad range of industries have relied on Rimini Street as their trusted application enterprise software products and services provider. To learn more, please visit http://www.riministreet.com , follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn .
Forward-Looking Statements
Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may,” “should,” “would,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “seem,” “seek,” “continue,” “future,” “will,” “expect,” “outlook” or other similar words, phrases or expressions. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, the duration of and economic, operational and financial impacts on Rimini Street’s business of the COVID-19 pandemic, as well as the actions taken by governmental authorities, clients or others in response to the COVID-19 pandemic; catastrophic events that disrupt Rimini Street’s business or that of its current and prospective clients, changes in the business environment in which Rimini Street operates, including inflation and interest rates, and general financial, economic, regulatory and political conditions affecting the industry in which Rimini Street operates; adverse developments in pending litigation or in the government inquiry or any new litigation; Rimini Street’s need and ability to raise additional equity or debt financing on favorable terms and Rimini Street’s ability to generate cash flows from operations to help fund increased investment in Rimini Street’s growth initiatives; the sufficiency of Rimini Street’s cash and cash equivalents to meet its liquidity requirements; the terms and impact of Rimini Street’s outstanding 13.00% Series A Preferred Stock; changes in taxes, laws and regulations; competitive product and pricing activity; difficulties of managing growth profitably; the customer adoption of Rimini Street’s recently introduced products and services, including its Application Management Services (AMS), Rimini Street Advanced Database Security, and services for Salesforce Sales Cloud and Service Cloud products, in addition to other products and services Rimini Street expects to introduce in the near future; the loss of one or more members of Rimini Street’s management team; uncertainty as to the long-term value of Rimini Street’s equity securities; and those risks discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on August 5, 2020 and as updated from time to time by other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.
© 2020 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.
1 Marketwire: Oracle Releases Oracle’s PeopleSoft 9.2, March 18, 2013: https://yhoo.it/2Cj1VwV
View source version on businesswire.com: https://www.businesswire.com/news/home/20200930005176/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
